Hemorrhoids - National Institute of Diabetes and Digestive and
... Hemorrhoids are swollen and inflamed veins around the anus or in the lower rectum. The rectum is the last part of the large intestine leading to the anus. The anus is the opening at the end of the digestive tract where bowel contents leave the body. External hemorrhoids are located under th ...
... Hemorrhoids are swollen and inflamed veins around the anus or in the lower rectum. The rectum is the last part of the large intestine leading to the anus. The anus is the opening at the end of the digestive tract where bowel contents leave the body. External hemorrhoids are located under th ...
Alopecia Areata - Providers - AmeriHealth Caritas Pennsylvania
... Anthralin, topical and intralesional steroids and cyclosporine are among several therapeutic agents that have efficacy in both disorders. Based on the impressive therapeutic responses seen in those with psoriasis treated with alefacept, a similarly beneficial outcome is tentatively anticipated with ...
... Anthralin, topical and intralesional steroids and cyclosporine are among several therapeutic agents that have efficacy in both disorders. Based on the impressive therapeutic responses seen in those with psoriasis treated with alefacept, a similarly beneficial outcome is tentatively anticipated with ...
COPD Today - American Thoracic Society
... metered dose inhaler (MDI), which releases a fixed amount of medicine. It is best to use an MDI that has a dose counter that you can look at so you will know how much medicine is left in the inhaler. For MDIs without a dose counter, you will need to know how many puffs your inhaler holds and how man ...
... metered dose inhaler (MDI), which releases a fixed amount of medicine. It is best to use an MDI that has a dose counter that you can look at so you will know how much medicine is left in the inhaler. For MDIs without a dose counter, you will need to know how many puffs your inhaler holds and how man ...
Pediatric Neurology Review
... side effects – drowsiness, orthostasis, dysrhythmia (EKG) may require 6-12 week treatment to determine efficacy anti-epileptics (topiramate, valproic acid, carbamazepine, neurontin) calcium channel blockers (verapamil) serotonin agonists (cyproheptadine, methysergide) vitamins (B2 / riboflavin, ...
... side effects – drowsiness, orthostasis, dysrhythmia (EKG) may require 6-12 week treatment to determine efficacy anti-epileptics (topiramate, valproic acid, carbamazepine, neurontin) calcium channel blockers (verapamil) serotonin agonists (cyproheptadine, methysergide) vitamins (B2 / riboflavin, ...
... This practice guideline was approved in July 2007 and published in October 2007. A guideline watch, summarizing significant developments in the scientific literature since publication of this guideline, may be available in the Psychiatric Practice section of the APA Web site at www.psych.org. The Work ...
Antibodies to Chlamydia trachomatis heat shock proteins in women
... Similar scarring reactions in the conjunctivae were produced in guinea pigs by a Triton X-100 extract of C. trachomatis or of the GPIC strain of C. psittaci suggesting a genus-specific component (Watkins et al., 1986). When the primary infection was induced at another mucosal site delayed type hyper ...
... Similar scarring reactions in the conjunctivae were produced in guinea pigs by a Triton X-100 extract of C. trachomatis or of the GPIC strain of C. psittaci suggesting a genus-specific component (Watkins et al., 1986). When the primary infection was induced at another mucosal site delayed type hyper ...
Management of STEMI ACC/AHA Guidelines
... • Morphine remains Class I for STEMI although may increase adverse events in UA/NSTEMI • NSAID medications increase mortality, reinfarction, and heart failure in proportion to degree of COX-2 selectivity – Discontinue on admission for STEMI – Do not initiate during acute phase of management ACC/AHA ...
... • Morphine remains Class I for STEMI although may increase adverse events in UA/NSTEMI • NSAID medications increase mortality, reinfarction, and heart failure in proportion to degree of COX-2 selectivity – Discontinue on admission for STEMI – Do not initiate during acute phase of management ACC/AHA ...
MINISTRY OF EDUCATION AND SCIENCE KYRGYZ REPUBLIC
... Creating a curriculum stimulate demand and proposals submitted by the chairs of the specialized medical disciplines. As a result, somebody has a strategy of integration goals and learning objectives, was the curricula, linking teaching both "vertical" (between adjacent courses), and on "horizontal" ...
... Creating a curriculum stimulate demand and proposals submitted by the chairs of the specialized medical disciplines. As a result, somebody has a strategy of integration goals and learning objectives, was the curricula, linking teaching both "vertical" (between adjacent courses), and on "horizontal" ...
Current hypotheses for the underlying biology of amyotrophic lateral
... A growing number of studies support the hypothesis that selective degeneration of motor neurons in ALS is not a cell-autonomous process; specifically, neighboring astrocytes contribute to disease progression (Fig).42 In the mid-1990s, defects in astroglia-specific glutamate transporters were identif ...
... A growing number of studies support the hypothesis that selective degeneration of motor neurons in ALS is not a cell-autonomous process; specifically, neighboring astrocytes contribute to disease progression (Fig).42 In the mid-1990s, defects in astroglia-specific glutamate transporters were identif ...
Diagnosis and management of psoriasis and psoriatic arthritis in
... age but peaks in the second and third decades of life. The course of the disease is characterised by relapses and remissions but the condition tends to persist throughout life. Over the past 20 years there have been many developments in the understanding of the genetic, molecular and cellular mechan ...
... age but peaks in the second and third decades of life. The course of the disease is characterised by relapses and remissions but the condition tends to persist throughout life. Over the past 20 years there have been many developments in the understanding of the genetic, molecular and cellular mechan ...
Lorazepam Injection, USP, CIV (4 mg/mL)
... motor vehicle, or engage in hazardous or other activities requiring attention and coordination, must be individualized. It is recommended that no patient engage in such activities for a period of 24 to 48 hours or until the effects of the drug, such as drowsiness, have subsided, whichever is longer. ...
... motor vehicle, or engage in hazardous or other activities requiring attention and coordination, must be individualized. It is recommended that no patient engage in such activities for a period of 24 to 48 hours or until the effects of the drug, such as drowsiness, have subsided, whichever is longer. ...
Shoulder Pain and Mobility Deficits: Adhesive Capsulitis
... These guidelines are not intended to be construed or to serve as a standard of medical care. Standards of care are determined on the basis of all clinical data available for an individual patient and are subject to change as scientific knowledge and technology advance and patterns of care evolve. Th ...
... These guidelines are not intended to be construed or to serve as a standard of medical care. Standards of care are determined on the basis of all clinical data available for an individual patient and are subject to change as scientific knowledge and technology advance and patterns of care evolve. Th ...
Herceptin (trastuzumab) Data Sheet
... asymptomatic, the physician should consider discontinuing therapy if no clinical benefit of Herceptin therapy has been seen. The safety of continuation or resumption of Herceptin in patients who experience cardiac dysfunction has not been prospectively studied. If symptomatic cardiac failure develop ...
... asymptomatic, the physician should consider discontinuing therapy if no clinical benefit of Herceptin therapy has been seen. The safety of continuation or resumption of Herceptin in patients who experience cardiac dysfunction has not been prospectively studied. If symptomatic cardiac failure develop ...
DEXTROAMPHETAMINE SULFATE EXTENDED
... Pre-Existing Psychosis – Administration of stimulants may exacerbate symptoms of behavior disturbance and thought disorder in patients with a pre-existing psychotic disorder. Bipolar Illness – Particular care should be taken in using stimulants to treat ADHD in patients with comorbid bipolar disorde ...
... Pre-Existing Psychosis – Administration of stimulants may exacerbate symptoms of behavior disturbance and thought disorder in patients with a pre-existing psychotic disorder. Bipolar Illness – Particular care should be taken in using stimulants to treat ADHD in patients with comorbid bipolar disorde ...
Systematic review and cost-effectiveness evaluation of `pill-in
... and treat disease, and improve rehabilitation and long-term care. The research findings from the HTA programme directly influence decision-making bodies such as the National Institute for Health and Clinical Excellence (NICE) and the National Screening Committee (NSC). HTA findings also help to impr ...
... and treat disease, and improve rehabilitation and long-term care. The research findings from the HTA programme directly influence decision-making bodies such as the National Institute for Health and Clinical Excellence (NICE) and the National Screening Committee (NSC). HTA findings also help to impr ...
High dose interleukin-2 (Aldesleukin)
... based on a better understanding of clinical features predicting outcomes [9]-[11]. At the same time, the number of doses of IL-2 being administered per course has decreased, reducing toxicity without an apparent impact on efficacy [1],[2],[7]-[10],[12]-[14]. These trials have stipulated the standard ...
... based on a better understanding of clinical features predicting outcomes [9]-[11]. At the same time, the number of doses of IL-2 being administered per course has decreased, reducing toxicity without an apparent impact on efficacy [1],[2],[7]-[10],[12]-[14]. These trials have stipulated the standard ...
Drug therapy for low cardiac output syndrome in paediatric patients
... LCOS develops in approximately 25% of paediatric patients following open heart surgery [10] and is characterised by a transient drop in cardiac output 6-18 hours after surgery [11]. Poor organ perfusion, tachycardia, oliguria or cardiac arrest with and without metabolic acidosis and widened arterial ...
... LCOS develops in approximately 25% of paediatric patients following open heart surgery [10] and is characterised by a transient drop in cardiac output 6-18 hours after surgery [11]. Poor organ perfusion, tachycardia, oliguria or cardiac arrest with and without metabolic acidosis and widened arterial ...
Overview
... MEDLINE, PREMEDLINE, EMBASE, Cochrane Library and other databases. IP overview: irreversible electroporation for treating pancreatic cancer ...
... MEDLINE, PREMEDLINE, EMBASE, Cochrane Library and other databases. IP overview: irreversible electroporation for treating pancreatic cancer ...
avandaryl tablets
... • Administer AVANDARYL at least 4 hours prior to colesevelam. (2.1) • Dose increases should be accompanied by careful monitoring for adverse events related to fluid retention. (2.2) • Do not exceed the maximum recommended daily dose of 8 mg rosiglitazone and 4 mg glimepiride. (2.3) • Do not initiate ...
... • Administer AVANDARYL at least 4 hours prior to colesevelam. (2.1) • Dose increases should be accompanied by careful monitoring for adverse events related to fluid retention. (2.2) • Do not exceed the maximum recommended daily dose of 8 mg rosiglitazone and 4 mg glimepiride. (2.3) • Do not initiate ...
The Dizzy Patient: A Clear-Headed Approach
... right and a sensation of falling to the left. There is no history of hearing loss or tinnitus, nor is there an associated diplopia, dysarthria, or weakness. Many years before, she was thrown from a horse and struck her head, with resultant severe vertigo, which cleared gradually over a six-week peri ...
... right and a sensation of falling to the left. There is no history of hearing loss or tinnitus, nor is there an associated diplopia, dysarthria, or weakness. Many years before, she was thrown from a horse and struck her head, with resultant severe vertigo, which cleared gradually over a six-week peri ...
Anal and rectal diseases explained
... When stool enters the rectum (which is a highly compliant organ), it distends and the internal anal sphincter (which is normally contracted) relaxes while the external anal sphincter remains closed. This process is called the rectoanal inhibitory reflex and is defective in Hirschsprung’s disease. Wh ...
... When stool enters the rectum (which is a highly compliant organ), it distends and the internal anal sphincter (which is normally contracted) relaxes while the external anal sphincter remains closed. This process is called the rectoanal inhibitory reflex and is defective in Hirschsprung’s disease. Wh ...
HIGHLIGHTS OF PRESCRIBING INFORMATION These
... ABILIFY MAINTENA is only to be administered by intramuscular injection by a healthcare professional. The recommended starting and maintenance dose of ABILIFY MAINTENA is 400 mg monthly (no sooner than 26 days after the previous injection). For patients who have never taken aripiprazole, establish to ...
... ABILIFY MAINTENA is only to be administered by intramuscular injection by a healthcare professional. The recommended starting and maintenance dose of ABILIFY MAINTENA is 400 mg monthly (no sooner than 26 days after the previous injection). For patients who have never taken aripiprazole, establish to ...
National Medical Policy Subject: Vitiligo
... While there are different regimens, excimer laser therapy is generally given twice weekly, with or without topical drugs, up to 6 months. Each treatment takes only a few minutes. There are several manufacturers of excimer lasers, including some specifically approved for the treatment of vitiligo by ...
... While there are different regimens, excimer laser therapy is generally given twice weekly, with or without topical drugs, up to 6 months. Each treatment takes only a few minutes. There are several manufacturers of excimer lasers, including some specifically approved for the treatment of vitiligo by ...
Management of multiple sclerosis
Several therapies for multiple sclerosis (MS) exist, although there is no known cure. Multiple sclerosis is a chronic inflammatory demyelinating disease that affects the central nervous system (CNS).The most common initial course of the disease is the relapsing-remitting subtype, which is characterized by unpredictable attacks (relapses) followed by periods of relative remission with no new signs of disease activity. After some years, many of the people who have this subtype begin to experience neurologic decline without acute relapses. When this happens it is called secondary progressive multiple sclerosis. Other, less common, courses of the disease are the primary progressive (decline from the beginning without attacks) and the progressive-relapsing (steady neurologic decline and superimposed attacks). Different therapies are used for patients experiencing acute attacks, for patients who have the relapsing-remitting subtype, for patients who have the progressive subtypes, for patients without a diagnosis of MS who have a demyelinating event, and for managing the various consequences of MS.The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability. As with any medical treatment, medications used in the management of MS may have several adverse effects, and many possible therapies are still under investigation. At the same time different alternative treatments are pursued by many patients, despite the paucity of supporting, comparable, replicated scientific study.This article focuses on therapies for standard MS; borderline forms of MS have particular treatments that are excluded.